Search research articles
Contact Us
Filters
Showing results (41-50 of 127) with videos related to
Page
of 13
Sort By:
British Journal of Haematology
|
November 19, 2015
Delineating outcomes of patients with diffuse large b cell lymphoma using the national comprehensive cancer network-international prognostic index and positron emission tomography-defined remission status; a population-based analysis
Mark J Bishton, Simon Hughes, Faith Richardson, et al.
Blood
|
January 14, 2021
Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells
Paul J Collins, Christopher P Fox, Lindsay George, et al.
Frontiers in Immunology
|
November 19, 2019
Non-uniform <i>in vivo</i> Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease
David M Burns, Gordon B Ryan, Caroline M Harvey, et al.
Rheumatology (Oxford, England)
|
October 31, 2021
Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood tests during long-term treatment: cohort study using data from the Clinical Practice Research Datalink Gold and Aurum
Georgina Nakafero, Matthew J Grainge, Tim Card, et al.
British Journal of Haematology
|
November 24, 2018
Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma
Christopher P Fox, Elizabeth H Phillips, Jeffery Smith, et al.
BMC Cancer
|
September 10, 2022
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma
Julia Wendler, Christopher P Fox, Elke Valk, et al.
British Journal of Haematology
|
January 22, 2024
The management of newly diagnosed large B-cell lymphoma: A British Society for Haematology Guideline
Christopher P Fox, Sridhar Chaganti, Graham McIlroy, et al.
RMD Open
|
March 7, 2024
Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation
Abhishek Abhishek, Matthew Grainge, Tim Card, et al.
The Lancet. Haematology
|
July 5, 2021
Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma
Sean H Lim, Nicola Campbell, Marina Johnson, et al.
British Journal of Haematology
|
May 19, 2025
Management of relapsed or refractory large B-cell lymphoma: A British Society for Haematology Guideline
Sridhar Chaganti, Christopher P Fox, Bernard D Maybury, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 127) with videos related to
Sort By:
Page
of 13
British Journal of Haematology
|
November 19, 2015
Delineating outcomes of patients with diffuse large b cell lymphoma using the national comprehensive cancer network-international prognostic index and positron emission tomography-defined remission status; a population-based analysis
Mark J Bishton, Simon Hughes, Faith Richardson, et al.
Blood
|
January 14, 2021
Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells
Paul J Collins, Christopher P Fox, Lindsay George, et al.
Frontiers in Immunology
|
November 19, 2019
Non-uniform <i>in vivo</i> Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease
David M Burns, Gordon B Ryan, Caroline M Harvey, et al.
Rheumatology (Oxford, England)
|
October 31, 2021
Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood tests during long-term treatment: cohort study using data from the Clinical Practice Research Datalink Gold and Aurum
Georgina Nakafero, Matthew J Grainge, Tim Card, et al.
British Journal of Haematology
|
November 24, 2018
Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma
Christopher P Fox, Elizabeth H Phillips, Jeffery Smith, et al.
BMC Cancer
|
September 10, 2022
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma
Julia Wendler, Christopher P Fox, Elke Valk, et al.
British Journal of Haematology
|
January 22, 2024
The management of newly diagnosed large B-cell lymphoma: A British Society for Haematology Guideline
Christopher P Fox, Sridhar Chaganti, Graham McIlroy, et al.
RMD Open
|
March 7, 2024
Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation
Abhishek Abhishek, Matthew Grainge, Tim Card, et al.
The Lancet. Haematology
|
July 5, 2021
Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma
Sean H Lim, Nicola Campbell, Marina Johnson, et al.
British Journal of Haematology
|
May 19, 2025
Management of relapsed or refractory large B-cell lymphoma: A British Society for Haematology Guideline
Sridhar Chaganti, Christopher P Fox, Bernard D Maybury, et al.
Page
of 13